Drug labeling allowed to detect illegal resale of expensive medicines

Print 07 November 2017
GMP News

A joint operation conducted by the Main Directorate for Economic Security and Countering Corruption of the Russian Ministry of Internal Affairs, the Department for Economic Security and Countering Corruption of the Russian Ministry of Internal Affairs for St. Petersburg and the Leningrad Region, together with the employees of Roszdravnadzor, uncovered the illegal resale of expensive drugs MabThera and Acerbia, previously shipped to the City Clinical Oncological Dispensary of Saint-Petersburg, a state budgetary healthcare institution, and other medical institutions of the region under the 7 Nosologies, a federal program.

The law enforcement authorities established the fact of the illegal sale of 1364 packages of these drugs in a total amount of 54,852,734 rubles, that caused especially large scale material damage to the state.

A criminal case was initiated on the fact of especially large scale fraud, and the investigation is under way.

Detection of the illegal resale of expensive pharmaceutical products became possible due to implementation of the pilot project on drug labeling.

Source

Return